Hyphens Pharma International Limited (SGX:1J5)

Revenue by Product

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Specialty Pharma Principals	124.25M
Specialty Pharma Principals Growth	21.58%
Medical Hypermart and Digital	43.63M
Medical Hypermart and Digital Growth	2.06%
Proprietary Brands	27.55M
Proprietary Brands Growth	7.39%

Revenue by Geography

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Singapore	90.89M
Singapore Growth	6.94%
Vietnam	57.11M
Vietnam Growth	16.52%
Malaysia	25.78M
Malaysia Growth	49.69%
Other	21.63M
Other Growth	11.72%